Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.
about
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients.Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorecMutanome and expression of immune response genes in microsatellite stable colon cancerThe prognostic value of Microsatellite Instability, KRAS, BRAF and PIK3CA mutations in stage II colon cancer patients.The prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff?Loss of RUNX3 expression is an independent adverse prognostic factor in diffuse large B-cell lymphoma.Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review.Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
P2860
Q33798842-D3895645-171D-4C47-9CDA-30603A2C19EAQ35839745-2581F19B-F6D1-4FE4-9D80-5E7E72B008F1Q36939031-B214F251-4ED4-4ED5-B0C4-7DF89482113CQ36993030-2AA80EEB-1353-49E3-93ED-7A33170C24CCQ37054795-8CD11FCF-685D-46C9-A537-A61F8C20ED57Q37109573-A96E29C4-3ECC-4869-B7B7-603C0DD5D553Q37170486-7A6E25A5-0696-42DB-9872-6D0DC4F0942FQ37256316-A4428D47-6E21-45C2-B4DD-93A6E9526E88Q38380322-0DD10AA0-B4B8-4E84-A55F-9B096E915D0BQ38670250-A88B0C4C-0AFC-4449-9B5E-C3E0683F3509Q39377846-1982262A-495F-418B-B625-4410B5C2E35EQ40411498-190B8CC8-6E26-4212-877C-E863BF8A5332
P2860
Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@ast
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@en
type
label
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@ast
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@en
prefLabel
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@ast
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@en
P2093
P2860
P1433
P1476
Molecular subtypes in stage II ...... and loss of RUNX3 and CDKN2A.
@en
P2093
Hartwig Kørner
Jon Arne Søreide
Marianne Berg
Oddmund Nordgaard
Satu Oltedal
P2860
P304
P356
10.1371/JOURNAL.PONE.0122391
P407
P577
2015-04-16T00:00:00Z